Strategic Analysis of the Global Omega-3 Pharmaceutical Market

News provided by

Dec 30, 2013, 09:13 ET

NEW YORK, Dec. 30, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Analysis of the Global Omega-3 Pharmaceutical Market
http://www.reportlinker.com/p01921034/Strategic-Analysis-of-the-Global-Omega-3-Pharmaceutical-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Growing Consumer Need and Regulatory Friendliness Drive Market Growth

This research service provides strategic insights into omega-3 fatty acid in pharmaceutical applications. The global omega-3 pharmaceutical market is emerging and presents immense potential. Omega-3 supplied as dietary supplements are formulated with less than 50% of EPA and DHA, causing a deficit in nutritional balance and eventually leading to more capsule consumption per day. Inadequate omega-3 dosage in dietary supplements has turned consumers towards pharmaceutical omega-3, resulting in high demand. Consumers increasingly prefer high-concentrated omega-3, as it reduces the dosage and the number of capsules required per day. In this study, the base year is 2012 and the forecast runs from 2013-2016.

Executive Summary

•The omega-3 pharmaceutical market is an emerging market that presents immense potential.
•Inefficiency of low concentrated omega-3 dietary supplement to satisfy the nutritional requirements has led to the development of a highly concentrated omega-3 pharmaceutical market.
•Regulatory friendliness, robust scientific evidence, and consumer favor for balanced nutrition are the key drivers for the omega-3 pharmaceutical market.
•Fluctuating raw material price and a few disproved claims are the major restrictions impacting the total revenue of market participants.
•High research and development cost is the main market challenge. Market participants must effectively address these costs to boost growth.

Research Scope and Methodology

•This research service provides strategic insights into omega-3 fatty acid in pharmaceutical applications.
•The study covers the global markets, geographically.
•The base year for this market insight is 2012, with a market study period of 2011 to 2016.
•The study discusses the market dynamics of omega-3 in pharmaceutical applications.
•Average prices are presented in US dollars.
•The study determines the demand for omega-3 fatty acids as a pharmaceutical ingredient.

Omega-3 Fatty Acids—Introduction

•Polyunsaturated fatty acids (PUFAs) are essential fatty acids and vital to health. The most common polyunsaturated fatty acids are omega-3 and omega-6.
•PUFAs are precursors of prostaglandins and eicosanoids, which function in controlling blood pressure, clotting blood, regulating growth, and regulating and activating the immune system.
•The human body cannot produce PUFAs on its own, hence they are substituted through foods, dietary supplements, and functional foods.
•Omega-3 fatty acids regulate the production of eicosanoid in the human body. Eicosanoids are proven to contribute to heart diseases, arthritis, asthma, and stroke.
•Omega-3 fatty acids are classified based on the length of their carbon chain. The main types include
- Alpha Linoleic Acid (ALA)
- Stearidonic Acid (SDA)
- Eicosapentaenoic Acid (EPA)
- Docosapentaenoic Acid (DPA)
- Docosahexaenoic Acid (DHA)
•EPA and DHA are the 2 important fatty acids that promote health. These 2 fatty acids are explored in detail in this insight.

Omega-3 Fatty Acids—Health Benefits

•Improved Cardiovascular Health
•Improved Brain Development
•Improved Joint Health
•Improved Visual Acuity
•Reduced Symptoms of Depression
•Cancer Prevention
•Protection Against Type II Diabetes
•Relieving Asthma

Improved Cardiovascular Health
Several research and clinical studies have proven that omega-3 fatty acids reduce the deposition of triglycerides in the arteries. The triglyceride concentration in the blood is decreased by reducing the concentration of low-density lipoproteins and very-low-density lipoproteins. Omega-3 further lowers the heartbeat, thereby reducing the blood pressure and improving the arterial elasticity. Omega-3 also initiates the synthesis of an anti-inflammatory agent, prostaglandin.

Improved Brain Development
DHA is an important fatty acid required for proper development of the brain in fetuses and infants. DHA is also being added to health drinks to improve the alertness of the brain.

Improved Joint Health
Omega-3 fatty acids are proven to stimulate the synthesis of anti-inflammatory agents in humans; therefore, it reduces the symptoms of rheumatoid arthritis. Clinical studies were done to analyze the effect of EPA and DHA in joint health and the results prove that they improve bone density.

Improved Visual Activity
DHA improves the vision of infants, as it is deposited in the retina of the eyes of the fetus during the final trimester of pregnancy.

Table of Contents

1. Executive Summary
2. Omega-3—Market Overview
3. Market Dynamics—Omega-3 Pharmaceutical Market
4. Pharmaceutical Omega-3—Total Market
5. Appendix
6. The Frost & Sullivan Story

To order this report: Strategic Analysis of the Global Omega-3 Pharmaceutical Market
http://www.reportlinker.com/p01921034/Strategic-Analysis-of-the-Global-Omega-3-Pharmaceutical-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication